Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJB14 is a type II transmembrane co-chaperone of the endoplasmic reticulum, part of the Hsp40 family, where its primary function is to bind Hsc70/Hsp70 and regulate their ATPase and substrate binding activities[1][3][4][5]. DNAJB14 promotes the proper folding and trafficking of client proteins, prevents aggregation of misfolded proteins, and facilitates their degradation via the ERAD pathway[1][2][3][4][5]. Together with DNAJB12, DNAJB14 also promotes maturation of specific potassium channels by stabilizing nascent channel subunits and facilitating oligomerization[2][3]. Overexpression of DNAJB14 leads to formation of specialized nuclear membrane structures (DJANGOS) and has a role in ER penetration by some viruses, such as SV40[1][3]. Disease associations (e.g., cystic fibrosis, post-vaccinal encephalitis) are reported at the genetic level but with little mechanistic data available[3]. No evidence supports direct clinical targeting or established use as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member B14 (DNAJB14).